Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 2
1985 4
1986 2
1988 2
1989 1
1991 2
1993 3
1994 3
1995 4
1996 5
1997 6
1998 10
1999 6
2000 6
2001 3
2002 3
2003 7
2004 6
2005 4
2006 4
2007 5
2008 7
2009 7
2010 12
2011 3
2012 8
2013 6
2014 12
2015 10
2016 12
2017 6
2018 14
2019 13
2020 8
2021 5
2022 1
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

195 results

Results by year

Filters applied: . Clear all
Page 1
Reply.
van Buuren HR, Lammers WJ, Hansen BE, Hirschfield GM. van Buuren HR, et al. Gastroenterology. 2016 Jun;150(7):1689-1690. doi: 10.1053/j.gastro.2016.05.001. Epub 2016 May 6. Gastroenterology. 2016. PMID: 27156831 No abstract available.
Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A Double-Blind, Randomized, Placebo-Controlled Trial.
de Vries E, Bolier R, Goet J, Parés A, Verbeek J, de Vree M, Drenth J, van Erpecum K, van Nieuwkerk K, van der Heide F, Mostafavi N, Helder J, Ponsioen C, Oude Elferink R, van Buuren H, Beuers U; Netherlands Association for the Study of the Liver-Cholestasis Working Group. de Vries E, et al. Among authors: van buuren h. Gastroenterology. 2021 Feb;160(3):734-743.e6. doi: 10.1053/j.gastro.2020.10.001. Epub 2020 Oct 5. Gastroenterology. 2021. PMID: 33031833 Clinical Trial.
Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis.
Harms MH, van Buuren HR, Corpechot C, Thorburn D, Janssen HLA, Lindor KD, Hirschfield GM, Parés A, Floreani A, Mayo MJ, Invernizzi P, Battezzati PM, Nevens F, Ponsioen CY, Mason AL, Kowdley KV, Lammers WJ, Hansen BE, van der Meer AJ. Harms MH, et al. Among authors: van buuren hr. J Hepatol. 2019 Aug;71(2):357-365. doi: 10.1016/j.jhep.2019.04.001. Epub 2019 Apr 11. J Hepatol. 2019. PMID: 30980847
Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase.
Murillo Perez CF, Harms MH, Lindor KD, van Buuren HR, Hirschfield GM, Corpechot C, van der Meer AJ, Feld JJ, Gulamhusein A, Lammers WJ, Ponsioen CY, Carbone M, Mason AL, Mayo MJ, Invernizzi P, Battezzati PM, Floreani A, Lleo A, Nevens F, Kowdley KV, Bruns T, Dalekos GN, Gatselis NK, Thorburn D, Trivedi PJ, Verhelst X, Parés A, Janssen HLA, Hansen BE; GLOBAL PBC Study Group. Murillo Perez CF, et al. Among authors: van buuren hr. Am J Gastroenterol. 2020 Jul;115(7):1066-1074. doi: 10.14309/ajg.0000000000000557. Am J Gastroenterol. 2020. PMID: 32618657
Reply.
Oey RC, Spaander MCW, van Buuren HR, de Man RA. Oey RC, et al. Among authors: van buuren hr. Hepatology. 2019 Nov;70(5):1875-1876. doi: 10.1002/hep.30781. Hepatology. 2019. PMID: 31127643 Free PMC article. No abstract available.
Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study.
Lammers WJ, van Buuren HR, Hirschfield GM, Janssen HL, Invernizzi P, Mason AL, Ponsioen CY, Floreani A, Corpechot C, Mayo MJ, Battezzati PM, Parés A, Nevens F, Burroughs AK, Kowdley KV, Trivedi PJ, Kumagi T, Cheung A, Lleo A, Imam MH, Boonstra K, Cazzagon N, Franceschet I, Poupon R, Caballeria L, Pieri G, Kanwar PS, Lindor KD, Hansen BE; Global PBC Study Group. Lammers WJ, et al. Among authors: van buuren hr. Gastroenterology. 2014 Dec;147(6):1338-49.e5; quiz e15. doi: 10.1053/j.gastro.2014.08.029. Epub 2014 Aug 23. Gastroenterology. 2014. PMID: 25160979
Reply.
Holster IL, Tjwa ET, Moelker A, Kuipers EJ, van Buuren HR. Holster IL, et al. Among authors: van buuren hr. Hepatology. 2016 Nov;64(5):1817-1818. doi: 10.1002/hep.28664. Epub 2016 Jul 8. Hepatology. 2016. PMID: 27240057 No abstract available.
[Primary biliary cirrhosis].
Kuiper EM, den Ouden-Muller JW, van Buuren HR. Kuiper EM, et al. Among authors: van buuren hr. Ned Tijdschr Geneeskd. 2009;153:A483. Ned Tijdschr Geneeskd. 2009. PMID: 19900324 Review. Dutch.
HLA-DPA1*02:01~B1*01:01 is a risk haplotype for primary sclerosing cholangitis mediating activation of NKp44+ NK cells.
Zecher BF, Ellinghaus D, Schloer S, Niehrs A, Padoan B, Baumdick ME, Yuki Y, Martin MP, Glow D, Schröder-Schwarz J, Niersch J, Brias S, Müller LM, Habermann R, Kretschmer P, Früh T, Dänekas J, Wehmeyer MH, Poch T, Sebode M; International PSC Study Group (IPSCSG); Ellinghaus E, Degenhardt F, Körner C, Hoelzemer A, Fehse B, Oldhafer KJ, Schumacher U, Sauter G, Carrington M, Franke A, Bunders MJ, Schramm C, Altfeld M. Zecher BF, et al. Gut. 2024 Jan 5;73(2):325-337. doi: 10.1136/gutjnl-2023-329524. Gut. 2024. PMID: 37788895 Free PMC article.
195 results